The concept of cellular immunotherapy fluctuated and declined. Jimin Medical and Nanhua Biotech fell to a standstill, Tailin Biotech fell by more than 8%, and Nanjing Xinbai and Sihuan Biotech followed suit.
细胞免疫治疗概念震荡回落，济民医疗、南华生物跌停，泰林生物跌超8%，南京新百、四环生物等跟跌。
The concept of cellular immunotherapy fluctuated and declined. Jimin Medical and Nanhua Biotech fell to a standstill, Tailin Biotech fell by more than 8%, and Nanjing Xinbai and Sihuan Biotech followed suit.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.